Sorry, you need to enable JavaScript to visit this website.

Competitive Grants Program

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.

Sign Up for Alerts Details
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    PARP-Inhibitor Combination Treatments: Biomarker Testing, Safety, and Efficacy in a Rapidly Changing Metastatic Prostate Cancer
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    Pediatric pneumococcal carriage and serotype distribution surveillance: prospective studies in South-East Asia, 2025-2026
    Release Date:
    Review Process: Pfizer Internal
    Research Vaccines India, Indonesia, Malaysia, Philippines, Singapore, Taiwan, Thailand, Vietnam
    Advancing Health Care Professionals’ knowledge and understanding of adult and maternal vaccination against respiratory infection
    Release Date:
    Review Process: Pfizer Internal
    Education Vaccines Austria, Belgium, Bulgaria, Croatia, Cyprus, Czech Republic, Estonia, Finland, Greece, Hungary, Ireland, Israel, Latvia, Lithuania, Luxembourg, Malta, Netherlands, Norway, Poland, Portugal, Romania, Slovakia (Slovak Republic), Slovenia, Ukraine
    Review and analysis of serotype distribution and burden of pneumococcal disease in children younger than 5 years – Post vac era
    Release Date:
    Review Process: Pfizer Internal
    Research Vaccines Burkina Faso, Congo, The Democratic Republic, Cote D'ivoire, Ethiopia, Ghana, Mozambique, Pakistan, Senegal, Sudan, Tanzania, United Republic of
    The Clinical Application of ATM-AVI in Patients with CRE Infections, including MBL-Producing CRE
    Release Date:
    Review Process: Pfizer Internal
    Research Hospital China, Hong Kong
    COVID-19 Disease Burden on the High Risk Population
    Release Date:
    Review Process: Pfizer Internal
    Education Vaccines All
    New Research Areas to Improve Diagnosis and Treatment of Inflammatory Bowel Disease
    Release Date:
    Review Process: Expert Review Panel
    Research Inflammation & Immunology USA
    Actionable Biomarker and Genetic Testing in Cancer: Education for Advanced Practice Providers (APPs)
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    Unmet Needs and Emerging Data in Patients with High-Risk Non-Muscle Invasive Bladder Cancer (NMIBC)
    Release Date:
    Partner: Astellas
    Review Process: Pfizer Internal
    Education Oncology USA
    Interdisciplinary Collaboration for the Management of Severe Alopecia Areata in Patients with Comorbidities
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology USA
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Appropriate Immunisations in Adult Patients with Immune-Mediated Inflammatory Conditions
    Release Date:
    Review Process:
    Improving the Clinical Management of Uncontrolled Acromegaly
    Release Date:
    Review Process:
    Antimicrobial Stewardship in the Asia-Pacific Region
    Release Date:
    Review Process:
    Lysosomal Storage Disorders Fellowship for Nurse Practitioners
    Release Date:
    Review Process:
    Hemophilia PUP Registry
    Release Date:
    Review Process:
    Quality Improvement Initiatives:Improving Screening and Diagnosis of Atrial Fibrillation and Optimizing Treatment and Management
    Release Date:
    Review Process:
    Appropriate Immunisations in Adult Patients with Immune-Mediated Inflammatory Conditions
    Release Date:
    Review Process:
    Accelerating the Detection, Diagnosis and Initial Treatment of Psoriatic Arthritis
    Release Date:
    Review Process:
    Improving the Identification and Management of Patients with Atrial Fibrillation (AF) and venous thromboembolism (VTE)
    Release Date:
    Review Process:
    Medication Optimization in Primary Care
    Release Date:
    Review Process:
    Quality Improvement Activities to Prevent Fatal Pulmonary Thromboembolism
    Release Date:
    Review Process:
    Increasing Rates of BRCA Testing in Patients with Breast Cancer
    Release Date:
    Review Process: